Search Results - "Fanola, L"

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients by Bohula, Erin A, Wiviott, Stephen D, McGuire, Darren K, Inzucchi, Silvio E, Kuder, Julia, Im, KyungAh, Fanola, Christina L, Qamar, Arman, Brown, Conville, Budaj, Andrzej, Garcia-Castillo, Armando, Gupta, Milan, Leiter, Lawrence A, Weissman, Neil J, White, Harvey D, Patel, Tushar, Francis, Bruce, Miao, Wenfeng, Perdomo, Carlos, Dhadda, Shobha, Bonaca, Marc P, Ruff, Christian T, Keech, Anthony C, Smith, Steven R, Sabatine, Marc S, Scirica, Benjamin M

“…In this cardiovascular safety trial, lorcaserin facilitated sustained weight loss without a higher risk of major adverse cardiovascular events than that with…”
Get full text

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial by Fanola, Christina L, Ruff, Christian T, Murphy, Sabina A, Jin, James, Duggal, Anil, Babilonia, Noe A, Sritara, Piyamitr, Mercuri, Michele F, Kamphuisen, Pieter W, Antman, Elliott M, Braunwald, Eugene, Giugliano, Robert P

“…Background Anticoagulation in patients with malignancy and atrial fibrillation is challenging because of enhanced risks for thrombosis and bleeding and the…”
Get full text

Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial by Fanola, Christina L., Morrow, David A., Cannon, Christopher P., Jarolim, Petr, Lukas, Mary Ann, Bode, Christoph, Hochman, Judith S., Goodrich, Erica L., Braunwald, Eugene, O'Donoghue, Michelle L.

“…Background Interleukin‐6 (IL‐6) is an inflammatory cytokine implicated in plaque instability in acute coronary syndrome (ACS). We aimed to evaluate the…”
Get full text

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial by Fanola, Christina L, Giugliano, Robert P, Ruff, Christian T, Trevisan, Marco, Nordio, Francesco, Mercuri, Michele F, Antman, Elliott M, Braunwald, Eugene

“…The choice between initiating a non-vitamin K antagonist oral anticoagulant (NOAC) and a vitamin K antagonist (VKA) in patients with atrial fibrillation (AF)…”
Get full text

2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines by Isselbacher, Eric M., Preventza, Ourania, Hamilton Black, James, Augoustides, John G., Beck, Adam W., Bolen, Michael A., Braverman, Alan C., Bray, Bruce E., Brown-Zimmerman, Maya M., Chen, Edward P., Collins, Tyrone J., DeAnda, Abe, Fanola, Christina L., Girardi, Leonard N., Hicks, Caitlin W., Hui, Dawn S., Schuyler Jones, William, Kalahasti, Vidyasagar, Kim, Karen M., Milewicz, Dianna M., Oderich, Gustavo S., Ogbechie, Laura, Promes, Susan B., Gyang Ross, Elsie, Schermerhorn, Marc L., Singleton Times, Sabrina, Tseng, Elaine E., Wang, Grace J., Woo, Y. Joseph

“…The "2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease" provides recommendations to guide clinicians in the diagnosis, genetic…”
Get full text

Incidence of severe renal dysfunction among individuals taking warfarin and implications for non–vitamin K oral anticoagulants by Fanola, Christina L., MD, MSc, Mooney, Deirdre, MD, Cowan, Andrew J., MD, Ko, Darae, MD, Sisson, Emily K., MA, Henault, Lori E., MPH, Tripodis, Yorghos, PhD, Hylek, Elaine M., MD, MPH

“…Background The purpose of this study is to assess incidence and risk factors for severe renal dysfunction in patients requiring oral anticoagulation to help…”
Get full text

Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran by Fanola, Christina L

“…Venous thromboembolism (VTE) is a disease state that carries significant morbidity and mortality, and is a known cause of preventable death in hospitalized and…”
Get full text

Design of an innovative beam monitor for particle therapy for the simultaneous measurement of beam fluence and energy by Sacchi, R, Cartiglia, N, Cenna, F, Fanola, L, Ferrero, M, Giordanengo, S, Marchetto, F, Monaco, V, Vignati, A, Varasteh Anvar, M, Cirio, R

Get full text

Quality assurance of carbon ion and proton beams: A feasibility study for using the 2D MatriXX detector by Varasteh Anvar, M, Attili, A, Ciocca, M, Donetti, M, Fanola Guarachi, L.K, Fausti, F, Giordanengo, S, Marchetto, F, Molinelli, S, Monaco, V, Sacchi, R, Vignati, A, Cirio, R

“…Highlights • The MatriXX detector is proposed for daily quality assurance in scanned ion beam therapy centers. • The detector was tested with proton and carbon…”
Get full text

2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines by Isselbacher, Eric M, Preventza, Ourania, Hamilton Black Iii, James, Augoustides, John G, Beck, Adam W, Bolen, Michael A, Braverman, Alan C, Bray, Bruce E, Brown-Zimmerman, Maya M, Chen, Edward P, Collins, Tyrone J, DeAnda, Jr, Abe, Fanola, Christina L, Girardi, Leonard N, Hicks, Caitlin W, Hui, Dawn S, Jones, William Schuyler, Kalahasti, Vidyasagar, Kim, Karen M, Milewicz, Dianna M, Oderich, Gustavo S, Ogbechie, Laura, Promes, Susan B, Ross, Elsie Gyang, Schermerhorn, Marc L, Times, Sabrina Singleton, Tseng, Elaine E, Wang, Grace J, Woo, Y Joseph

“…The "2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease" provides recommendations to guide clinicians in the diagnosis, genetic…”
Get full text

Incident Heart Failure and Long-Term Risk for Venous Thromboembolism by Fanola, Christina L., Norby, Faye L., Shah, Amil M., Chang, Patricia P., Lutsey, Pamela L., Rosamond, Wayne D., Cushman, Mary, Folsom, Aaron R.

“…Heart failure (HF) hospitalization places patients at increased short-term risk for venous thromboembolism (VTE). Long-term risk for VTE associated with…”
Get full text

Complex arterial patterning in an anatomical donor by Kahn, Chase I., MacNeil, Maryann, Fanola, Christina L., Whitney, Elizabeth R.

“…Case reports of individuals with a single variant or a limited number of localized variants are plentiful; however, systematic, whole-body study of cerebral,…”
Get full text

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk by Bergmark, Brian A, Scirica, Benjamin M, Steg, Ph Gabriel, Fanola, Christina L, Gurmu, Yared, Mosenzon, Ofri, Cahn, Avivit, Raz, Itamar, Bhatt, Deepak L

“…Abstract Aims Optimal blood pressure for prevention of cardiovascular (CV) events in patients with Type 2 diabetes mellitus (T2DM) remains uncertain and there…”
Get full text

Decreased mortality with local versus general anesthesia in endovascular aneurysm repair for ruptured abdominal aortic aneurysm in the Vascular Quality Initiative database by Faizer, Rumi, Weinhandl, Eric, El Hag, Selma, Le Jeune, Stacey, Apostolidou, Ioanna, Shafii, Susan M., Lee, Cheong J., Rosenberg, Michael S., Reed, Amy, Fanola, Christina L.

“…Endovascular aneurysm repair (EVAR) is an accepted approach for patients presenting with ruptured abdominal aortic aneurysm (rAAA) and suitable anatomy. The…”
Get full text

A simple method to increase the current range of the TERA chip in charged particle therapy applications by Cirio, R., Fausti, F., Fanola Guarachi, L., Giordanengo, S., Marchetto, F., Mazza, G., Monaco, V., Sacchi, R., Talpacci, E., Varasteh Anvar, M., Vignati, A.

“…The development of the next generation of accelerators for charged particle radiotherapy aims to reduce dimensions and operational complexity of the machines…”
Get full text

Vascular Genetics: Presentations, Testing, and Prognostics by Aday, Aaron W., Kreykes, Sarah E., Fanola, Christina L.

“…Purpose of review Numerous studies have begun to unravel the genetic basis of not only aortic disease but also other forms of commonly encountered vascular…”
Get full text

TIMI‐AF score and cardiovascular events in vitamin K antagonists‐naïve outpatients with atrial fibrillation by Pérez Cabeza, Alejandro Isidoro, Bravo Marques, Rafael, Chinchurreta Capote, Pedro Antonio, Ruiz Mateas, Francisco, Fanola, Christina L., Rosas Cervantes, Gabriel, González Correa, Jose Antonio, Valle Alberca, Almudena, Mesa Prado, Fidel, López Tejero, Sergio, Ruff, Christian Thomas

“…Background The TIMI‐AF score predicts poor outcomes in patients with atrial fibrillation (AF) and guides selection of anticoagulant therapy by identifying…”
Get full text

The ELIMED transport and dosimetry beamline for laser-driven ion beams by Romano, F., Schillaci, F., Cirrone, G.A.P., Cuttone, G., Scuderi, V., Allegra, L., Amato, A., Amico, A., Candiano, G., De Luca, G., Gallo, G., Giordanengo, S., Guarachi, L. Fanola, Korn, G., Larosa, G., Leanza, R., Manna, R., Marchese, V., Marchetto, F., Margarone, D., Milluzzo, G., Petringa, G., Pipek, J., Pulvirenti, S., Rizzo, D., Sacchi, R., Salamone, S., Sedita, M., Vignati, A.

“…A growing interest of the scientific community towards multidisciplinary applications of laser-driven beams has led to the development of several projects…”
Get full text

189 - Design of an innovative beam monitor for particle therapy for the simultaneous measurement of beam fluence and energy by Sacchi, R., Cartiglia, N., Cenna, F., Fanola, L., Ferrero, M., Giordanengo, S., Marchetto, F., Monaco, V., Vignati, A., Varasteh Anvar, M., Cirio, R.

Get full text

MO‐F‐CAMPUS‐T‐05: Design of An Innovative Beam Monitor for Particle Therapy for the Simultaneous Measurement of Beam Fluence and Energy by Sacchi, R, Cartiglia, N, Cenna, F, Guarachi, L Fanola, Ferrero, M, Giordanengo, S, Marchetto, F, Monaco, V, Vignati, A, Anvar, M Varasteh, Cirio, R

“…Purpose: Monitoring the prescribed dose in particle therapy is typically carried out by using parallel plate ionization chambers working in transmission mode…”
Get full text